Abstract
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetologia |
Vol/bind | 56 |
Udgave nummer | 2 |
Sider (fra-til) | 298-310 |
Antal sider | 13 |
ISSN | 0012-186X |
DOI | |
Status | Udgivet - 2013 |
Bibliografisk note
CURIS 2013 NEXS 069Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. / Albrechtsen, Anders; Grarup, Niels; Li, Y.; Sparsø, Thomas Hempel; Tian, G.; Cao, H.; Jiang, T.; Kim, S.Y.; Korneliussen, Thorfinn Sand; Li, Q.; Nie, C.; Wu, R.; Skotte, Line; Morris, A.P.; Ladenvall, C.; Cauchi, S.; Stancáková, A.; Andersen, G.; Astrup, Arne; Banasik, Karina; Bennett, A.J.; Bolund, Lars; Charpentier, G.; Chen, Y.; Dekker, J.M.; Doney, A.S.F.; Dorkhan, M.; Forsen, T.; Frayling, T.M.; Groves, C.J.; Gui, Y.; Hallmans, G.; Hattersley, A.T.; He, K.; Hitman, G.A.; Holmkvist, J.; Huang, S.; Jiang, H.; Jin, X.; Justesen, Johanne Marie; Kristiansen, Karsten; Kuusisto, J.; Lajer, M.; Lantieri, O.; Li, W.; Liang, H.; Liao, Q.; Liu, X.; Ma, T.; Ma, X.; Manijak, M.P.; Marre, M.; Mokrosinski, Jacek; Morris, A.D.; Mu, B.; Nielsen, A.A.; Nijpels, G.; Nilsson, P.; Palmer, C.N.A.; Rayner, N.W.; Renström, F.; Ribel-Madsen, Rasmus; Robertson, N.; Rolandsson, O.; Rossing, P.; Schwartz, Thue W.; Slagboom, P.E.; Sterner, M.; Tang, M.; Tarnow, L.; Tuomi, T.; Van't Riet, E.; van Leeuwen, N.; Varga, T.V.; Vestmar, Marie Aare; Walker, M.; Wang, B.; Wang, Y.; Wu, H.; Xi, F.; Yengo, L.; Yu, C.; Zhang, X.; Zhang, J.; Zhang, Q.; Zhang, W.; Zheng, H.; Zhou, Y.; Altshuler, D.; 't Hart, L.M.; Franks, P.W.; Balkau, B.; Froguel, P.; McCarthy, M.I.; Laakso, M.; Groop, L.; Christensen, C.; Brandslund, I.; Lauritzen, T.; Witte, D.R.; Linneberg, A.; Jørgensen, Torben; Hansen, Torben; Wang, Jun; Nielsen, Rasmus; Pedersen, Oluf.
I: Diabetologia, Bind 56, Nr. 2, 2013, s. 298-310.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes
AU - Albrechtsen, Anders
AU - Grarup, Niels
AU - Li, Y.
AU - Sparsø, Thomas Hempel
AU - Tian, G.
AU - Cao, H.
AU - Jiang, T.
AU - Kim, S.Y.
AU - Korneliussen, Thorfinn Sand
AU - Li, Q.
AU - Nie, C.
AU - Wu, R.
AU - Skotte, Line
AU - Morris, A.P.
AU - Ladenvall, C.
AU - Cauchi, S.
AU - Stancáková, A.
AU - Andersen, G.
AU - Astrup, Arne
AU - Banasik, Karina
AU - Bennett, A.J.
AU - Bolund, Lars
AU - Charpentier, G.
AU - Chen, Y.
AU - Dekker, J.M.
AU - Doney, A.S.F.
AU - Dorkhan, M.
AU - Forsen, T.
AU - Frayling, T.M.
AU - Groves, C.J.
AU - Gui, Y.
AU - Hallmans, G.
AU - Hattersley, A.T.
AU - He, K.
AU - Hitman, G.A.
AU - Holmkvist, J.
AU - Huang, S.
AU - Jiang, H.
AU - Jin, X.
AU - Justesen, Johanne Marie
AU - Kristiansen, Karsten
AU - Kuusisto, J.
AU - Lajer, M.
AU - Lantieri, O.
AU - Li, W.
AU - Liang, H.
AU - Liao, Q.
AU - Liu, X.
AU - Ma, T.
AU - Ma, X.
AU - Manijak, M.P.
AU - Marre, M.
AU - Mokrosinski, Jacek
AU - Morris, A.D.
AU - Mu, B.
AU - Nielsen, A.A.
AU - Nijpels, G.
AU - Nilsson, P.
AU - Palmer, C.N.A.
AU - Rayner, N.W.
AU - Renström, F.
AU - Ribel-Madsen, Rasmus
AU - Robertson, N.
AU - Rolandsson, O.
AU - Rossing, P.
AU - Schwartz, Thue W.
AU - Slagboom, P.E.
AU - Sterner, M.
AU - Tang, M.
AU - Tarnow, L.
AU - Tuomi, T.
AU - Van't Riet, E.
AU - van Leeuwen, N.
AU - Varga, T.V.
AU - Vestmar, Marie Aare
AU - Walker, M.
AU - Wang, B.
AU - Wang, Y.
AU - Wu, H.
AU - Xi, F.
AU - Yengo, L.
AU - Yu, C.
AU - Zhang, X.
AU - Zhang, J.
AU - Zhang, Q.
AU - Zhang, W.
AU - Zheng, H.
AU - Zhou, Y.
AU - Altshuler, D.
AU - 't Hart, L.M.
AU - Franks, P.W.
AU - Balkau, B.
AU - Froguel, P.
AU - McCarthy, M.I.
AU - Laakso, M.
AU - Groop, L.
AU - Christensen, C.
AU - Brandslund, I.
AU - Lauritzen, T.
AU - Witte, D.R.
AU - Linneberg, A.
AU - Jørgensen, Torben
AU - Hansen, Torben
AU - Wang, Jun
AU - Nielsen, Rasmus
AU - Pedersen, Oluf
N1 - CURIS 2013 NEXS 069
PY - 2013
Y1 - 2013
N2 - AIMS/HYPOTHESIS: Human complex metabolic traits are in part regulated by genetic determinants. Here we applied exome sequencing to identify novel associations of coding polymorphisms at minor allele frequencies (MAFs) >1% with common metabolic phenotypes. METHODS: The study comprised three stages. We performed medium-depth (8×) whole exome sequencing in 1,000 cases with type 2 diabetes, BMI >27.5 kg/m(2) and hypertension and in 1,000 controls (stage 1). We selected 16,192 polymorphisms nominally associated (p¿1%. In stage 2 we identified 51 potential associations with one or more of eight metabolic phenotypes covered by 45 unique polymorphisms. In meta-analyses of stage 2 and stage 3 results, we demonstrated robust associations for coding polymorphisms in CD300LG (fasting HDL-cholesterol: MAF 3.5%, p¿=¿8.5¿×¿10(-14)), COBLL1 (type 2 diabetes: MAF 12.5%, OR 0.88, p¿=¿1.2¿×¿10(-11)) and MACF1 (type 2 diabetes: MAF 23.4%, OR 1.10, p¿=¿8.2¿×¿10(-10)). CONCLUSIONS/INTERPRETATION: We applied exome sequencing as a basis for finding genetic determinants of metabolic traits and show the existence of low-frequency and common coding polymorphisms with impact on common metabolic traits. Based on our study, coding polymorphisms with MAF above 1% do not seem to have particularly high effect sizes on the measured metabolic traits.
AB - AIMS/HYPOTHESIS: Human complex metabolic traits are in part regulated by genetic determinants. Here we applied exome sequencing to identify novel associations of coding polymorphisms at minor allele frequencies (MAFs) >1% with common metabolic phenotypes. METHODS: The study comprised three stages. We performed medium-depth (8×) whole exome sequencing in 1,000 cases with type 2 diabetes, BMI >27.5 kg/m(2) and hypertension and in 1,000 controls (stage 1). We selected 16,192 polymorphisms nominally associated (p¿1%. In stage 2 we identified 51 potential associations with one or more of eight metabolic phenotypes covered by 45 unique polymorphisms. In meta-analyses of stage 2 and stage 3 results, we demonstrated robust associations for coding polymorphisms in CD300LG (fasting HDL-cholesterol: MAF 3.5%, p¿=¿8.5¿×¿10(-14)), COBLL1 (type 2 diabetes: MAF 12.5%, OR 0.88, p¿=¿1.2¿×¿10(-11)) and MACF1 (type 2 diabetes: MAF 23.4%, OR 1.10, p¿=¿8.2¿×¿10(-10)). CONCLUSIONS/INTERPRETATION: We applied exome sequencing as a basis for finding genetic determinants of metabolic traits and show the existence of low-frequency and common coding polymorphisms with impact on common metabolic traits. Based on our study, coding polymorphisms with MAF above 1% do not seem to have particularly high effect sizes on the measured metabolic traits.
U2 - 10.1007/s00125-012-2756-1
DO - 10.1007/s00125-012-2756-1
M3 - Journal article
C2 - 23160641
VL - 56
SP - 298
EP - 310
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - 2
ER -